Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for Testosterone Suppression and Breast Development in Transwomen
NCT04534881Phase 2Terminated
- Sponsor
- Saint Louis University
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in Gender incongruence (GI), sponsored by Saint Louis University. Started Oct 2020; status: terminated.
02
Drugs
progesterone
03
Conditions
Gender incongruence (GI)
Beyond the preview
Go deeper on NCT04534881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534881.